2026年3月2日，医脉通科技有限公司（02192）发布截至2026年2月28日的股份变动月报表。公告显示，公司注册股本维持在50,000,000,000股，面值每股USD 0.00001，总额USD 500,000，未发生变动。
本月普通股已发行股份（不含库存股）由上月底的737,960,875股增至738,360,875股，共新增400,000股。该增发源于前期授予的首次公开发售前购股权，行使价为人民币0.38元/股，共募集资金人民币152,000元。截至本月底，普通股已发行股份总数为738,360,875股，库存股份仍为0股。
公司同时披露，除上述期权行使外，本月未进行任何股份回购或注销活动，亦无库存股份变动。公司认为已符合香港联交所《上市规则》所规定的最低公众持股量要求，并确认本次股份发行已遵守相关监管规定。
本公告由公司秘书杨艳玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.